Provided by Tiger Trade Technology Pte. Ltd.

Organon & Co

6.35
+0.02000.32%
Post-market: 6.350.00000.00%19:33 EDT
Volume:2.84M
Turnover:18.14M
Market Cap:1.65B
PE:8.82
High:6.48
Open:6.34
Low:6.32
Close:6.33
52wk High:15.88
52wk Low:6.18
Shares:259.98M
Float Shares:258.73M
Volume Ratio:0.85
T/O Rate:1.10%
Dividend:0.08
Dividend Rate:1.26%
EPS(TTM):0.7200
EPS(LYR):0.7200
ROE:30.56%
ROA:6.22%
PB:2.20
PE(LYR):8.82

Loading ...

Organon Q3 EPS USD 0.61

THOMSON REUTERS
·
Nov 10, 2025

Organon to present data from Phase 3 ADORING 1, ADORING 2 trials

TIPRANKS
·
Nov 10, 2025

Organon Reports Positive Phase 3 Results for VTAMA Cream in Children With Atopic Dermatitis

Reuters
·
Nov 08, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Block, Peloton Interactive

Reuters
·
Nov 08, 2025

Organon & Co expected to post earnings of 94 cents a share - Earnings Preview

Reuters
·
Nov 07, 2025

BUZZ-U.S. STOCKS ON THE MOVE-ANI Pharmaceuticals, Wendy's, nLIGHT

Reuters
·
Nov 07, 2025

BUZZ-Organon rises after agreeing to sell postpartum bleeding device to Laborie for up to $465 mln

Reuters
·
Nov 07, 2025

Organon Shares up 1.8% Premarket After Co Announces Agreement to Divest Its Jada System for up to $465 Million to Laborie

THOMSON REUTERS
·
Nov 07, 2025

Organon & Co. Director Grace Puma to Step Down After 2026 Annual Meeting

Reuters
·
Nov 07, 2025

Organon Sells JADA System to Laborie for Up to $465 Million

Reuters
·
Nov 07, 2025

Organon & Co: Approximately 100 Employees Are Expected to Transfer to Laborie as Part of Agreement

THOMSON REUTERS
·
Nov 07, 2025

Organon & Co - Deal Proceeds to Be Used for Debt Reduction

THOMSON REUTERS
·
Nov 07, 2025

Organon Announces Agreement to Divest Its Jada® System for up to $465 Million to Laborie

THOMSON REUTERS
·
Nov 07, 2025

Organon & Co - Deal Includes $440 Mln at Closing, $25 Mln Contingent Payment

THOMSON REUTERS
·
Nov 07, 2025

Press Release: Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025

Dow Jones
·
Nov 06, 2025

Organon & Co. to Release Third Quarter 2025 Results

Reuters
·
Nov 06, 2025

Organon Amends Filing to Disclose Executive Chair Compensation

Reuters
·
Oct 31, 2025

Organon (OGN) Is Down 26.2% After CEO Resignation and Audit Reveals Sales Practice Issues – What's Changed

Simply Wall St.
·
Oct 29, 2025

Organon & Co (OGN.US) Plunges on Internal Control Issues; Piper Sandler Slashes Target Price to $5

Stock News
·
Oct 28, 2025

This Drugmaker Made 'Improper' Sales to Meet Guidance. The Stock Plummets 25%. -- Barrons.com

Dow Jones
·
Oct 28, 2025